Company profile: Nutraceutix
1.1 - Company Overview
Company description
- Provider of specialty pharmaceutical and probiotic solutions, developing and commercializing prescription, over-the-counter, and nutritional products using controlled delivery technology. Develops water-soluble/insoluble and high/low-dose drugs in analgesic, cardiovascular, diabetes, anti-nausea, and pulmonary areas, with two US production sites and a global partner network.
Products and services
- Controlled Delivery Technology Platform: Engineers controlled-delivery systems for water-soluble and insoluble drugs, supporting high/low-dose formulations across analgesic, cardiovascular, diabetes, anti-nausea, and pulmonary indications
- Manufacturing Capabilities: Dual-site US operations with a global partner network source and supply probiotic products worldwide from two production sites and international partnerships
- Probiotic Strains and Solutions: Offers clinically proven probiotic strains and products, developed through innovative R&D and manufacturing expertise by Probi
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nutraceutix
Adrien Gagnon
HQ: Canada
Website
- Description: Provider of natural health vitamins, minerals, and supplements, including Oméga-3 Extra Fort for cardiovascular, cognitive, and mood support; Collagène Triple Action for collagen formation and joint health; Glucosamine Chondroïtine to relieve joint pain and support cartilage; Curcuma avec BioPerine for anti-inflammatory, liver, and digestive support; TendoFlex for tendinitis and plantar fasciitis pain; La nuit complète sleep aid.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adrien Gagnon company profile →
NattoPharma
HQ: Norway
Website
- Description: Provider of nutritional yeasts, probiotics, and active ingredients for dietary supplements, functional foods, beverages, and pharmaceuticals. Collaborates with brands to develop products including Quatrefolic, Lynside S. boulardii, and LANDKIND Pure Salidroside to support health benefits. Online inquiry form available.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NattoPharma company profile →
Akkermansia
HQ: Belgium
Website
- Description: Provider of bacteria-based biotic food supplements that promote weight management and address metabolic nutrition and inflammatory disorders; a biotechnology firm developing bacteria-derived supplement products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akkermansia company profile →
Probi
HQ: Sweden
Website
- Description: Provider of probiotics, developing, manufacturing, and distributing a wide range of solutions, including the lp299v strain and a probiotic portfolio aligned to health positions and application areas; offers customer support via email and phone.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Probi company profile →
Satipharm
HQ: Ireland
Website
- Description: Provider of cannabinoid-based health and wellbeing products manufactured from the cannabis plant, offering exceptional, consistent quality produced in a regulated, safe environment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Satipharm company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nutraceutix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nutraceutix
2.2 - Growth funds investing in similar companies to Nutraceutix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nutraceutix
4.2 - Public trading comparable groups for Nutraceutix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →